Gregson Norman A, Zhang Gaiping, Pritchard Jane, Wang Aiping, Sanvito Lara, Hayday Adrian C, Hughes Richard A C
Department of Clinical Neuroscience, King's College London School of Medicine, Guy's Hospital, London, UK.
J Peripher Nerv Syst. 2007 Mar;12(1):2-10. doi: 10.1111/j.1529-8027.2007.00112.x.
We produced a mouse monoclonal antibody using cDNA and peptide immunization against the putative second extra-cellular domain of human peripheral myelin protein 22 (PMP22). It reacted specifically with human PMP22 and not with other human myelin proteins and did not react with bovine, rat, or mouse PMP22. The antibody stained the compact myelin of human peripheral nerve motor and sensory axons and did not stain central nervous system tissue. PMP22 reactivity was detected in the spinal roots of the human fetus at 19-20 weeks of gestation. The staining pattern of the PMP22 antibody resembled that of a monoclonal antibody directed against the myelin protein zero.
